CTSS and Alzheimer disease: As the best-characterized inflammasome, studies found that NLRP3 was activated in AD (Saresella et al., 2016), which can be activated by cholesterol, cathepsin and also by the amyloid peptide (Duewell et al., 2010; Masters and O’Neill, 2011; Jo et al., 2016).